Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Artesunate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 349Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mangalam Drugs expanding anti-malaria APl portfolio with Pyronaridine
    Mangalam Drugs expanding anti-malaria APl portfolio with Pyronaridine

    21 Aug 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/mangalam-drugs-organics-expanding-anti-malaria-apl-portfolio-with-introduction-of-pyronaridine-16056

    INDIANPHARMAPOST
    21 Aug 2024
    Share Share
    Amivas' Artesunate Amivas (artesunate) Receives Approval in Europe
    Amivas' Artesunate Amivas (artesunate) Receives Approval in Europe

    23 Aug 2023

    // EMA

    https://www.ema.europa.eu/en/documents/overview/artesunate-amivas-epar-medicine-overview_en.pdf

    EMA
    23 Aug 2023
    Share Share
    AMIVAS Ireland Receives Authorisation from MHRA to Market Artesunate Amivas
    AMIVAS Ireland Receives Authorisation from MHRA to Market Artesunate Amivas

    13 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/amivas-ireland-ltd-receives-authorisation-from-the-medicines--healthcare-products-regulatory-agency-mhra-to-market-artesunate-amivas-artesunate-in-uk-for-initial-treatment-of-severe-malaria-301566099.html

    PRNEWSWIRE
    13 Jun 2022
    Share Share
    EU Commission Grants AMIVAS Ireland Ltd. Approval to Market artesunate
    EU Commission Grants AMIVAS Ireland Ltd. Approval to Market artesunate

    24 Nov 2021

    // ADNKRONOS

    https://www.adnkronos.com/eu-commission-grants-amivas-ireland-ltd-approval-to-market-artesunate-amivas-artesunate-in-the-eueea-for-initial-treatment-of-severe-malaria_rrElf2EIbqGM6RLWng5gN

    ADNKRONOS
    24 Nov 2021
    Share Share
    Enforcement Report - Week of October 13, 2021
    Enforcement Report - Week of October 13, 2021

    13 Oct 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-13-2021-1634124785.pdf

    FDA
    13 Oct 2021
    Share Share
    WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients
    WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients

    12 Aug 2021

    // M. Shields REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/who-led-trial-study-three-anti-inflammatory-drugs-covid-19-patients-2021-08-11/

    M. Shields REUTERS
    12 Aug 2021
    Share Share